Kev txhaj tshuaj Tirelizumab
Lub npe tshuaj: Tirellizumab txhaj
Cov khoom xyaw: Tirellizumab yog humanized IgG 4 anti-monoclonal antibody rau PD-1
Indications: Tirellizumab txhaj yog tsim nyog rau kev kho mob ntawm relapsed los yog refractory cov neeg mob nrog classic Hodgkin's lymphoma tom qab yam tsawg kawg thib ob-kab kab mob chemotherapy.
Kev txhaj tshuaj Tirelizumab yog siv los kho cov neeg mob uas muaj kab mob urothelial carcinoma (UC) uas muaj cov kab mob loj heev hauv zos lossis metastatic PD-L1 qhia ua tsis tau cov tshuaj platinum uas muaj cov tshuaj khomob nrog rau kev loj hlob hauv 12 lub hlis ntawm neoadjuvant lossis adjuvant chemotherapy.
Ua ke paclitaxel thiab carboplatin rau thawj kab kev kho mob hauv zos qib siab lossis metastatic squamous uas tsis yog mob qog noj ntshav me me.
Rau thawj kab kev kho mob ntawm cov neeg mob uas tsis yog-squamous non-small cell lung cancer (NSCLC). Lub caij no, NMPA tau raug pom zoo rau kev kho mob ntawm cov neeg mob hepatocellular carcinoma (HCC) kho nrog tsawg kawg ib txoj kev kho mob.
Specification: 10ml: 100mg
Lub neej txee: 24 lub hlis
Cim npe nrov: Tirellizumab txhaj tshuaj, Tuam Tshoj Tirellizumab txhaj tshuaj lwm tus neeg
